Within the tumor microenvironment, S100A9 is highly expressed by various myeloid cell populations (e.g., myeloid-derived suppressor cells) and plays a critical role in the formation of an immunosuppressive niche which favors tumor growth and drug resistance [10, 11]. The gene discussed is S100A9; the disease is neoplasm.